Perspectives from those who live it every day.
Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by… Read More »New Advances in Therapies: Five-Drug Combo
The following blog post was submitted and written by representatives at the Lustgarten Foundation. Johns Hopkins and the Sanger Institute published two papers in the journal Nature describing how pancreatic cancer develops far more slowly than once thought. Major media outlets covering the news included The New York Times, Bloomberg News, Reuters, CBS News, Science News, WebMD and Health Day. Read the Johns Hopkins' news release for more information.
The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, applauds the work of cooperating investigators at the Johns Hopkins Medical Institutions and the Sanger Institute on their groundbreaking research in the area of pancreatic cancer. The studies, which were reported online Wednesday, October 27, in Nature, affirm early detection and screening as promising areas of investigation that hold significant potential for saving lives.